183 institutional investment managers reported DNA positions in their Form 13F filings for Q2 2026, holding 36,189,025 shares worth $359M in total. BlackRock, Inc. reported the largest position.

Are funds buying or selling DNA?

In Q2 2026, 28 managers opened new DNA positions, 69 added, 38 trimmed and 19 sold out. Managers that filed in both quarters added a net 3,871,495 shares.

How current is this DNA institutional ownership data?

It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Funds · DNA

Who owns DNA?

Institutional ownership of Ginkgo Bioworks Holdings Inc. from Form 13F, Q2 2026

183 institutional managers reported holding Ginkgo Bioworks Holdings Inc. (DNA) in Form 13F filings for Q2 2026, with 36,189,025 shares worth $359M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 3,871,495 shares (+12.0%). 28 opened new positions and 19 sold out.

Funds holding: 183
Value held: $359M
New / sold out: 28 / 19
Net shares, same filers: +12.0%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of DNA

Fund	Value	Share of 13F holdings	Shares	Move
BlackRock, Inc.	$42.4M	11.8%	4,282,903	Added
Viking Global Investors LP	$35.4M	9.9%	3,577,128	Unchanged
Erste Asset Management GmbH	$25.9M	7.0%	2,536,939	Added
Baillie Gifford & Co	$23.7M	6.6%	2,391,649	Unchanged
Vanguard Capital Management LLC	$20.7M	5.8%	2,087,293	Added
Anchorage Capital Group, L.L.C.	$17.3M	4.8%	1,746,363	Unchanged
Legal & General Group Plc	$16.5M	4.6%	1,669,419	Added
State Street Corp	$14.6M	4.1%	1,472,370	Added
Geode Capital Management, LLC	$12.1M	3.4%	1,222,016	Added
Forbes J M & Co LLP	$9.9M	2.8%	999,911	Trimmed
Vanguard Portfolio Management LLC	$9.3M	2.6%	937,803	Added
Allianz Asset Management GmbH	$7.8M	2.2%	785,798	Added
UBS Group AG	$6.9M	1.9%	691,659	Added
Millennium Management LLC	$6.3M	1.8%	638,676	Added
AQR Capital Management LLC	$6.2M	1.7%	621,625	Added
SB Investment Advisers (uk) LTD	$6.1M	1.7%	610,729	Unchanged
Goldman Sachs Group Inc	$6.0M	1.7%	607,376	Trimmed
Bank of America Corp	$5.4M	1.5%	545,852	Added
Prescott Group Capital Management, L.L.C.	$5.4M	1.5%	541,845	Unchanged
Renaissance Technologies LLC	$5.3M	1.5%	539,856	Added
Northern Trust Corp	$4.0M	1.1%	405,141	Added
Charles Schwab Investment Management Inc	$3.9M	1.1%	394,607	Added
Exchange Traded Concepts, LLC	$3.6M	1.0%	358,783	Added
Dimensional Fund Advisors LP	$3.5M	1.0%	351,200	Added
Tudor Investment Corp Et Al	$3.3M	0.9%	335,710	Trimmed

Share of 13F holdings is each fund's shares as a share of the 36,189,025 DNA shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

BlackRock, Inc. Added+$6.3M
Erste Asset Management GmbH Added+$6.0M
Renaissance Technologies LLC Added+$4.4M
Vanguard Portfolio Management LLC Added+$3.7M
AQR Capital Management LLC Added+$3.2M
Acadian Asset Management LLC Added+$2.4M
Dimensional Fund Advisors LP Added+$2.2M
Geode Capital Management, LLC Added+$2.1M
Balance Capital Partners L.p. New+$2.0M
Vanguard Capital Management LLC Added+$1.7M

Biggest sellers in Q2 2026

Goldman Sachs Group Inc Trimmed-$3.2M
Morgan Stanley Trimmed-$3.1M
Jacobs Levy Equity Management, Inc Trimmed-$2.6M
Tudor Investment Corp Et Al Trimmed-$1.3M
Man Group plc Trimmed-$841K
Numerai GP LLC Trimmed-$704K
Peak6 LLC Sold out-$657K
ExodusPoint Capital Management, LP Trimmed-$503K
Dynamic Technology Lab Private Ltd Trimmed-$447K
Squarepoint Ops LLC Trimmed-$389K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $56.3M and sold $16.8M; 69 added and 38 trimmed.

Schedule 13D and 13G filings on DNA

Owners of more than 5% must file within days, so these can be newer than the 13F data.

2025-07-29VANGUARD GROUP INC SCHEDULE 13G filed by Ginkgo Bioworks Holdings Inc.Schedule 13G
2025-07-17BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G

Questions about DNA ownership

Who owns DNA stock?: 183 institutional investment managers reported DNA positions in their Form 13F filings for Q2 2026, holding 36,189,025 shares worth $359M in total. BlackRock, Inc. reported the largest position.
Are funds buying or selling DNA?: In Q2 2026, 28 managers opened new DNA positions, 69 added, 38 trimmed and 19 sold out. Managers that filed in both quarters added a net 3,871,495 shares.
How current is this DNA institutional ownership data?: It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to DNA by CUSIP. Options are left out. DNA news and filings · DNA insider trades · Top funds